伊索尼阿齐德增强了tigecycline的作用,可以杀死耐美西林的金黄色葡萄球菌
Xuan-Wei Chen1,2, Hao-Qing Chen3, Jia-Han Wu1
1State Key Laboratory of Bio-Control, Guangdong Key Laboratory of Pharmaceutical Functional Genes, School of Life Sciences, Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai), Sun Yat-sen University, Guangzhou, People's Republic of China.
伊索尼亚齐德可以增强tigecycline的作用.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 甲素耐药黄金葡萄球菌 (MRSA) 感染由于广泛的抗生素耐药性而构成重大治疗挑战.
- 迫切需要新的治疗策略,以有效打击MRSA感染.
研究的目的:
- 调查异化作为对tigecycline治疗MRSA感染的辅助剂的潜力.
- 阐明异化和tigecycline之间协同作用的潜在机制.
主要方法:
- 临床MRSA菌株的最小抑制度 (MIC) 测定.
- 杀菌杀菌实验和小鼠感染模型.
- 研究药物积累,膜损伤和质子驱动力 (PMF) 破坏.
主要成果:
- 异氧化显著增强了tigecycline对MRSA的杀死功效,降低了tigecycline的MIC.
- 异化通过调节通过PMF的流入和流出来增强细胞内tigecycline的积累.
- 这种组合会破坏细胞膜和PMF,而酸乙醇胺和心脏脂氨酸会取消协同效应.
结论:
- 异化可以作为有效的抗生素辅助剂重新使用,用于治疗MRSA感染的tigecycline.
- 这种组合疗法提供了一种有前途的新策略,用于对抗具有挑战性的细菌感染.
- 了解作用机制可以扩大抗生素与抗生素组合的治疗选择.
更多相关视频
07:28Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry
Published on: October 29, 2020
07:50Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
相关概念视频
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Antimicrobial Effectiveness
Development of Antibiotic Resistance
Desensitization and Tachyphylaxis
